YANG RICK purchased 18.4% of their position (937.50K shares) of SPYGLASS PHARMA, INC. on the open market
Open‑market purchase worth $15.00M — a significant purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+1.62M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.37M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.37M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+737.96K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+937.50K
Price / share
$16.00
Trade value
$15M
% of position
Net shares
+6.04M
Net value
$15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/9/2026 | C · Conversion | +1.62M | — | — | New position | 0.00 | 1.62M |
| Common Stock Indirect | 2/9/2026 | C · Conversion | +1.37M | — | — | 84.6% | 1.62M | 2.99M |
| Common Stock Indirect | 2/9/2026 | C · Conversion | +1.37M | — | — | 45.8% | 2.99M | 4.36M |
| Common Stock Indirect | 2/9/2026 | C · Conversion | +737.96K | — | — | 16.9% | 4.36M | 5.10M |
| Common Stock Indirect | 2/9/2026 | P · Purchase | +937.50K | $16.00 | $15M | 18.4% | 5.10M | 6.04M |
| Total | +6.04M | $15M | ||||||
Series B Preferred Stock
Common Stock
1.62M shares
Shares
−1.62M
Strike price
Held after
0.00
Exercisable
—
Series C-1 Preferred Stock
Common Stock
1.37M shares
Shares
−1.37M
Strike price
Held after
0.00
Exercisable
—
Series C-2 Preferred Stock
Common Stock
1.37M shares
Shares
−1.37M
Strike price
Held after
0.00
Exercisable
—
Series D Preferred Stock
Common Stock
737.96K shares
Shares
−737.96K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock1.62M shares | 2/9/2026 | C · Conversion | −1.62M | — | 0.00 | |
| Series C-1 Preferred Stock Indirect | Common Stock1.37M shares | 2/9/2026 | C · Conversion | −1.37M | — | 0.00 | |
| Series C-2 Preferred Stock Indirect | Common Stock1.37M shares | 2/9/2026 | C · Conversion | −1.37M | — | 0.00 | |
| Series D Preferred Stock Indirect | Common Stock737.96K shares | 2/9/2026 | C · Conversion | −737.96K | — | 0.00 |